LivePerson moves TASE holders to cash to remove a closing hurdle in the SoundHound merger
The amended agreement is not a new LivePerson turnaround story. It changes the Israeli closing path: shares held through the TASE clearing system move to cash consideration, capped at $7.5 million in aggregate, while the main closing conditions remain open.
LivePerson filed an update that is worth reading only as a closing document, not as a new operating story. The prior first-quarter analysis already moved the center of the debate from a standalone turnaround to the closing of the SoundHound transaction, cash, and customer retention until closing. The new update changes one component in that path: shares held through the Tel Aviv Stock Exchange clearing system are no longer expected to receive SoundHound stock, but cash consideration. The reason is not better operating performance. It is an Israeli securities-law issue that could have delayed the LivePerson stockholder meeting and the closing by several months if SoundHound had been required to prepare and file an Israeli prospectus. The right reading is therefore narrow but material. The amended agreement removes one local timing obstacle, but it does not remove the stockholder vote, Form S-4 effectiveness, foreign investment approvals, Nasdaq listing approval for SoundHound shares, the debt restructuring, or the absence of a material adverse effect. Investors are not getting proof that the business has recovered. They are getting evidence that the parties are willing to change consideration mechanics to avoid getting stuck at an Israeli procedural bottleneck.
The Israeli Change: Cash Instead Of A Local Prospectus Path
The update starts with the point that matters most to Israeli holders. After signing the original agreement in April, LivePerson and SoundHound determined that Israeli securities law could require SoundHound to prepare and file an Israeli prospectus for the issuance of SoundHound shares to holders whose LivePerson shares are held through the TASE clearing system, unless an exception or exemption applied. Without that exception or exemption, the stockholder meeting and the closing could have been delayed by several months.
The chosen solution is to change the form of consideration for those holders. Ordinary holders outside the TASE route continue to receive the right to SoundHound shares under the agreement's equity consideration formula. TASE shares are excluded from the first merger and move into a second merger, where they are converted into a right to receive cash.
That is the value of the filing. The dual listing and local trading framework created a real timing issue. The fix does not increase the total consideration, but it reduces the risk that an Israeli securities-law process pushes the transaction deeper into late 2026.
Consideration No Longer Looks The Same For Every Holder
The main merger consideration remains built around a base amount of $42.78453264 million, reduced by any LivePerson shortfall cash and increased by the exercise prices of in-the-money options. The SoundHound stock price used for the calculation is based on a ten-trading-day VWAP, with a $7 floor and a $12 cap. That was already the economic core of the original deal.
The change sits in the local pocket. Aggregate cash consideration for TASE shares is calculated based on their relative share of the fully diluted common number, but it is capped at $7.5 million. A holder whose shares are held through the TASE clearing system therefore does not receive the same forward exposure to SoundHound stock as a holder outside that route. The local holder receives a cash route, with a formula and a cap.
The distinction matters. The amendment does replace an Israeli prospectus risk with a cash path that should be simpler to execute. It also creates a different economic route between holders based on where the shares are held. It does not eliminate LivePerson's cash-shortfall mechanism, and it does not make the shareholder consideration fully certain. If LivePerson's cash balance, net of transaction expenses and actions around the 2026 notes, falls below the agreed threshold, the aggregate consideration can still be reduced.
Cash remains central to the read. The minimum cash level used in the shortfall calculation is $74 million, or $71 million if closing occurs in July, reduced by the principal amount of 2026 notes repurchased between April 1 and closing. LivePerson had $101.5 million of cash and cash equivalents at March 31, 2026, but that is a quarter-end number. By the closing date, transaction expenses, note repurchases, and operating needs determine how much of that cushion remains inside the consideration formula.
What Can Still Delay The Deal
The amended agreement improves the Israeli route, but it does not make the transaction closed. The core conditions still include approval by LivePerson stockholders, no legal impediment, required foreign investment approvals, Nasdaq approval for listing SoundHound shares issued in the merger, effectiveness of SoundHound's Form S-4, compliance with covenants, no material adverse effect on LivePerson, and completion of the notes restructuring.
The notes restructuring is not a side issue. Under the April framework, holders of the 2029 notes are expected to receive SoundHound shares based on an aggregate consideration amount of $178.00773368 million, plus cash for accrued interest and 65% of LivePerson excess cash. Holders of the second lien notes are expected to receive shares based on an aggregate consideration amount of $83.20773368 million, plus certain cash tied to repurchases of 2026 notes and 35% of excess cash. If the debt restructuring does not close, the merger itself can stall.
The timetable also has a hard edge. Either party can terminate the agreement if the merger is not completed by October 21, 2026, with a possible extension to December 5, 2026 if certain regulatory approvals have not been obtained. LivePerson may also owe SoundHound a $5 million termination fee plus expenses in specified circumstances, and where the fee relates to failure of the notes restructuring, expense reimbursement is capped at $3.75 million.
For investors, the filing does not shorten the entire condition list. It shows that the parties are dealing with one obstacle created by the Tel Aviv route, while the remaining proof points still come from the vote, registration, regulation, debt, and cash.
The Waiting Period Still Runs Through The Business
This is not a new turnaround story because the latest operating evidence already showed cost progress alongside commercial weakness. In the first quarter, revenue fell to $56.956 million from $64.700 million a year earlier, while operating loss narrowed to $1.751 million from $16.944 million. Operating cash flow was positive at $9.544 million, but the company also said it continued to observe slower-than-anticipated renewals and new business bookings, primarily driven by customer uncertainty around its financial stability.
That connects the merger to the business. If customers keep delaying renewals or reducing commitments while the company waits for closing, the deal is not only a legal process. It becomes a race between closing and further erosion in the revenue base. Deferred revenue rose to $57.987 million at the end of March from $54.295 million at the end of 2025, but contract acquisition costs fell to $20.856 million from $23.951 million. That is not enough to declare a full commercial recovery.
Debt reinforces the same point. LivePerson was in compliance at the end of March with the covenant requiring a minimum cash balance of $60 million, and its debt stack still includes current 2026 notes, 2029 notes, and second lien notes. Cash before closing is therefore not just a comfort metric. It affects covenants, the consideration formula, and the company's ability to get through the waiting period without a new pressure round.
Conclusion
LivePerson's update changes closing probability from the Israeli angle. The parties identified a local securities-law bottleneck that could have delayed the stockholder meeting and closing by several months, and chose to pay TASE-cleared holders in cash instead of routing them into SoundHound stock consideration. That is a narrow but real change: one timetable risk is reduced, and holders receive different economics depending on how their shares are held.
The remaining conditions are still heavy: vote, Form S-4, regulatory approvals, Nasdaq listing, debt restructuring, cash, and no material adverse effect. The expected TASE delisting date also gives local holders a bounded event window. Until closing actually occurs, the next filings need to show that LivePerson is not eroding customers or cash while waiting. If the amendment enables a faster closing, operating weakness may become less relevant for shareholders. If it merely removes one delay and the transaction keeps dragging on, LivePerson returns to the old test: customers, cash, and debt need to hold until the merger closes.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.